Hangzhou Tigermed Consulting Co., Ltd. Operating Cash Flow for the year ending December 31, 2024: USD 150.25 M

Hangzhou Tigermed Consulting Co., Ltd. Operating Cash Flow is USD 150.25 M for the year ending December 31, 2024, a -7.28% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
  • Hangzhou Tigermed Consulting Co., Ltd. Operating Cash Flow for the year ending December 31, 2023 was USD 162.04 M, a -17.63% change year over year.
  • Hangzhou Tigermed Consulting Co., Ltd. Operating Cash Flow for the year ending December 31, 2022 was USD 196.72 M, a -12.21% change year over year.
  • Hangzhou Tigermed Consulting Co., Ltd. Operating Cash Flow for the year ending December 31, 2021 was USD 224.08 M, a 46.46% change year over year.
  • Hangzhou Tigermed Consulting Co., Ltd. Operating Cash Flow for the year ending December 31, 2020 was USD 153.00 M, a 101.96% change year over year.
Key Data
Date Operating Cash Flow Capital Expenditure Net Cash Used For Investing Activities Net Cash Used Provided By Financing Activities